ArticlePloS one2021
Cost-effectiveness analysis of branded and authorized generic celecoxib for patients with chronic pain in Japan.
Yusuke Karasawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it